Elevance Health (ELV) Gross Profit (2009 - 2026)

Elevance Health (ELV) has 18 years of Gross Profit data on file, last reported at $13.9 billion in Q1 2026.

• Gross Profit for Q1 2026 came in at $13.9 billion, down 68.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.8 billion (down 46.31% YoY), and the FY2025 annual result was $176.4 billion, up 12.17% from the prior year.
• Gross Profit retreated to $13.9 billion in Q1 2026 per ELV's latest filing, from $68.1 billion in the prior quarter.
• Over five years, Gross Profit peaked at $119.8 billion in Q4 2024 and troughed at -$70.4 billion in Q4 2023.
• A 5-year average of $30.6 billion and a median of $38.4 billion in 2024 frame the typical range for Gross Profit.
• On a YoY basis, Gross Profit climbed as much as 749.6% in 2023 and fell as far as 231.84% in 2023.
• A 5-year view of Gross Profit shows it stood at $53.4 billion in 2022, then slumped by 231.84% to -$70.4 billion in 2023, then jumped by 270.21% to $119.8 billion in 2024, then slumped by 43.12% to $68.1 billion in 2025, then plunged by 79.62% to $13.9 billion in 2026.
• Business Quant data shows ELV's Gross Profit at $13.9 billion in Q1 2026, $68.1 billion in Q4 2025, and $3.7 billion in Q3 2025.